Hepatocarcinogenesis by Non-Genotoxic Compounds

  • R. Schulte-Hermann
  • W. Parzefall
  • W. Bursch
  • I. Timmermann-Trosiener


Many compounds have been found to produce liver tumors after long-term treatment of experimental animals, mostly rodents, without exhibiting detectable genotoxic activity or potential. These agents include phenobarbital, certain estrogens and progestins, hypolipidemic and other drugs as well as environmental pollutants such as DDT, hexachlorocyclohexane, phthalate plasticizers etc. After short-term treatment the agents induce liver growth and increases of certain enzymes which probably represents enhanced expression of specific gene programs. Mechanisms involved include stimulation of cell proliferation and inhibition of cell death (apoptosis).

In addition to negative tests for genotoxicity these agents generally are also negative when assayed for tumor initiating activity in the liver; however, many but not all compounds show tumor promoting activity. Tumor promotion may be due to overexpression of gene programs in initiated/preneoplastic cells in the liver; inhibition of death of preneoplastic cells by promoters seems to cause rapid growth of preneoplastic lesions. Possible implications for risk assessment are discussed.


Tumor Promoter Peroxisome Proliferators Cyproterone Acetate Liver Growth Preneoplastic Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Argyris, T.S., Magnus, D.R., 1968, The stimulation of liver growth and demethylase activity following phenobarbital treatment. Dev. Biol. 17: 187.Google Scholar
  2. Bieri, F., Bentley, P., Waechter, F., Stäubli, W., 1984, Use of primary cultures of adult rat hepatocytes to investigate mechanisms of action of nafenopin, a hepatocarcinogenic peroxisome proliferator. Carcinogenesis 5: 1033.PubMedCrossRefGoogle Scholar
  3. Bursch, W., Dusterberg, B., Schulte-Hermann, R., 1986, Growth, regression and cell death in rat liver as related to tissue levels of the hepatomitogen cyproterone acetate. Arch. Toxicol. 59: 221.PubMedCrossRefGoogle Scholar
  4. Bursch, W., Lauer, B,. Timmermann-Trosiener, I., Barthel, G., Schuppler, J., Schulte-Hermann, R., 1984, Controlled death ( Apoptosis) of normal and putative preneoplastic cells in rat liver following withdrawal of tumor promoters. Carcinogenesis 5: 453.PubMedCrossRefGoogle Scholar
  5. Bursch, W., Liehr, J., Sirbasku, D., Schulte-Hermann, R., 1988, Role of cell death for growth and regression of hormone-dependent H-301 hamster kidney tumors. in: “Chemical Carcinogenesis: Models and Mechanisms”, F. Feo, P. Pani, A. Columbano, R. Garcea (eds.), Plenum press, in press.Google Scholar
  6. Bursch, W., Taper, H.S., Lauer, B., Schulte-Hermann, R., 1985, Quantitative histological and histochemical studies on the occurrence and stages of controlled cell. death (apoptosis) during regression of rat liver hyperplasia. Virch. Arch. Cell Pathol. 50: 153.CrossRefGoogle Scholar
  7. Druckrey, H., 1967, Quantitative aspects in chemical carcinogenesis. UICC Monogr. 7: 60.Google Scholar
  8. Kunz, W., Schaude, G., Schmid, W., Siess, M., 1966, Lebervergrößerung durch Fremdstoffe. Naunjn Schmiedeberq’s Arch. 254: 470.CrossRefGoogle Scholar
  9. Moore, M.A., Kitagawa, T., 1986, Hepatocarcinogenesis in the rat: the effect of promoters and carcinogens in vivo and in vitro Int. Rev Cytol. 101: 125.PubMedCrossRefGoogle Scholar
  10. Ochs, H., Düsterberg, B., Günzel, P., Schulte-Hermann, R., 1986, Effect of tumor promoting contraceptive steroids on growth and drug metabolizing enzymes in rat liver. Cancer Res. 46: 1224.PubMedGoogle Scholar
  11. Parzefall, W., Galle, P.R., Schulte-Hermann, R., 1985, Effect of calf and rat serum on the induction of DNA synthesis and mitosis in primary cultures of adult rat hepatocytes by cyproterone acetate and epidermal growth factor. In Vitro Cell. Developmental Biology 21: 665.CrossRefGoogle Scholar
  12. Parzefall, W., Monschau, P., Schulte-Hermann, R., 1988, Induction by cyproterone acetate of DNA synthesis and mitosis in primary cultures of adult rat hepatocytes in serum free medium Biochem.Google Scholar
  13. submitted. Peraino, C., Fry, R.J.M., Staffeldt, E., 1971, Reduction and enhancement by phenobarbital of hepatocarcinogenesis induced in the rat by 2acetylaminofluorene. Cancer, Res, 31: 1506.Google Scholar
  14. Reddy, J.K., Lalwai, N.D., 1983, Carcinogenesis by hepatic peroxisome proliferators: Evaluation of the risk of hypolilpidemic drugs and industrial plasticizers to humans. Crit. Rev. Toxicol. 12: 1.PubMedCrossRefGoogle Scholar
  15. Schröter, H., Gerbracht, U., Schulte-Hermann, R., Effects of hypolipidemic agents on 2 different types of putative preneoplastic foci in rat liver. Naunyn Schmiedebe rgs Arch. 329: 26 (1985).Google Scholar
  16. Schröter, C., Parzefall, W., Schröter, H., Schulte-Hermann, R., 1987, Dose-response studies on the effects of a-, Band g-hexachlorocyclohexane on putative preneoplastic foci, monooxygenases, and growth in rat liver. ëançer. Res. 47: 80.Google Scholar
  17. Schulte-Hermann, R., 1974, Induction of liver growth by xenobiotic compounds and other stimuli. Crit. Rev. Toxicol. 3: 97.CrossRefGoogle Scholar
  18. Schulte-Hermann, R., 1985, Tumor promotion in the liver, Arch. Toxicol. 57: 147.PubMedCrossRefGoogle Scholar
  19. Schulte-Hermann, R., Bursch, W., Fesus, L., Kraupp, B., 1988, Cell death by apoptosis in normal, preneoplastic and neoplastic tissue. in: “Chemical Carcinogenesis: Models and Mechanisms”, F. Feo, P. Pani, A. Columbano, R. Garcea, eds., Plenum Press, in press.Google Scholar
  20. Schulte-Hermann, R., Schmitz, E., 1980, Feedback inhibition of hepatic DNA synthesis. Cell Tissue Kinet. 13: 371.PubMedGoogle Scholar
  21. Schulte-Hermann, R., Timmermann-Trosiener, I., Schuppler, J., 1982, Response of liver foci in rats to hepatic tumor promoters. Toxicol. Pathol. 10: 63.CrossRefGoogle Scholar
  22. Schulte-Hermann, R., Timmermann-Trosiener, I., Schuppler, J., 1983, Promotion of spontaneous preneoplastic cells in rat liver as a possible explanation of tumor production by non-mutagenic compounds. Cancer Res. 43: 839.PubMedGoogle Scholar
  23. Schulte-Hermann, R., Timmermann-Trosiener, I., Schuppler, J., 1986, Facilitated expression of adaptive responses to phenobarbital in putative pre-stages of liver cancer. Carcinogenesis 7: 1651.PubMedCrossRefGoogle Scholar
  24. Schulte-Hermann, R., Ochs, H., Bursch, W., Parzefall, W., 1988, Quantitative structure-activity studies on effects of sixteen different steroids on growth and monooxygenases of rat liver. Cancer Res. 48: 2462.PubMedGoogle Scholar
  25. Schulte-Hermann, R., Ohde, G., Schuppler, J., TimmermannTrosiener, I., 1981, Enhanced proliferation of putative preneoplastic cells in rat liver following treatment with the tumor promoters phenobarbital, exachlorocyclohexane, steroid compounds and nafenopin. Cancer Res. 41: 2556.PubMedGoogle Scholar
  26. Schulte-Hermann, R., Hoffmann, V., Landgraf, H., 1980, Adaptive responses of rat liver to the gestagen and anti-androgen cyproterone acetate and other inducers. III. Cytological changes. Chem. Biol. Interactions 31: 301.CrossRefGoogle Scholar
  27. Stäubli, W., Bentley, P., Bieri, F., Fröhlich, E., Waechter, F., 1984, Inhibitory effect of nafenopin upon the development of di ethylnitrosamine-induced enzyme-altered foci within the rat liver. Carcinogenesis 5: 41.PubMedCrossRefGoogle Scholar
  28. Ward, J.M., 1983, Increased susceptibility of livers of aged F344/NCr rats to the effects of phenobarbital on the incidence, morphology, and histochemistry of hepatocellular foci and neoplasms. J Nati Cancer Inst. 71: 815.Google Scholar
  29. Wyllie, A.H., Herr, J.F.R., Currie, A.R., 1980, Cell death: the significance of apoptosis. Int. Rev, Cytol 68: 251.CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1989

Authors and Affiliations

  • R. Schulte-Hermann
    • 1
  • W. Parzefall
    • 1
  • W. Bursch
    • 1
  • I. Timmermann-Trosiener
    • 1
  1. 1.Institute of Tumorbiology-Cancer ResearchUniversity of ViennaViennaAustria

Personalised recommendations